A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer.

Reha-Baris IncesuSimone MorraLukas ScheipnerFrancesco BarlettaAndrea BaudoCristina Cano GarciaStefano TapperoMattia Luca PiccinelliZhe TianFred SaadShahrokh F ShariatOttavio de CobelliCarlo TerroneFelix K H ChunLuca CarmignaniAlberto BrigantiSascha AhyaiNicola LongoDerya TilkiMarkus GraefenPierre I Karakiewicz

Published in: Japanese journal of clinical oncology (2024)

The survival improvement reported by the IGCCCG Update Consortium is also operational in non-seminoma testis cancer patients within the most contemporary SEER database. This observation indicates that the survival improvement is not only applicable to centres of excellence, but also applies to other institutions at large.

Keyphrases

germ cell
free survival
squamous cell carcinoma
small cell lung cancer
papillary thyroid
young adults
squamous cell
drug induced